Hemenway Trust Company »

Apimeds Pharmaceuticals Us I shares owned by Hemenway Trust Company

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Hemenway Trust Company from 13F filings

Historical chart of Hemenway Trust Company investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Hemenway Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Hemenway Trust Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $445k 250k 1.78

More positions owned by Hemenway Trust Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Apple (AAPL)
MasterCard Incorporated (MA)
Amazon (AMZN)
Abbott Laboratories (ABT)
Analog Devices (ADI)
TJX Companies (TJX)
Home Depot (HD)
Automatic Data Processing (ADP)
Raytheon Technologies Corp (RTX)
Advanced Micro Devices (AMD)
Schneider Elect Sa-unsp (SBGSY)
Johnson & Johnson (JNJ)

View all positions for Hemenway Trust Company

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Renaissance Technologies
XTX Topco
Hrt Financial
UBS Group
Jpmorgan Chase & Co

View all funds holding Apimeds Pharmaceuticals Us I